The inhibitory effects of EVO on JAK2/STAT3 signaling and MMP3 expression were stronger than those of AG490 (Figure 4E), suggesting that EVO is a strong inhibitor of tumor cell migration in colon cancer. Here, JAK2 is linked to malignant colon neoplasm.